6 questions investors should ask when evaluating psychedelic biotech companies
TechCrunch
APRIL 6, 2022
Once fringe, underground, illegal or just limited to ceremonial use by Indigenous cultures, psychedelics are going mainstream in medicinal form. Our fund has invested more than $15 million in companies developing psychedelic therapeutics.
98 
Let's personalize your content